Short interest for Emergent BioSolutions gives investors a sense of the degree to which investors are betting on the decline of Emergent BioSolutions's stock. Short interest data is updated every two weeks.

Emergent BioSolutions Stock (NYSE:EBS), Short Interest Report

Emergent BioSolutions

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

reports earnings

Earnings

News

Movers

Emergent reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of losses of 83 cents by 171.08%.

Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What&#39;s Going On With The Stock?

Beating,Estimates,Wall,Street,Prices,Stock,Market,Tickers,3d,Illustation

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ASPN

CVNA

FSLY

VSTS

XPEL

XRAY

Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results

Wall street shutter3

Dow Surges Over 100 Points; ConocoPhillips Earnings Miss Views

Emergent BioSolutions Inc

EMPIRE BANCSHARES INC by Empire Bancshares Inc.

Empire Bancshares Inc

Emergent BioSolutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and <a href="https://www.benzinga.com/24/05/38584875/nasdaq-jumps-over-100-points-kellanova-posts-upbeat-results">reported first-quarter financial results.</a>
The Details:
Emergent reported <a href="https://www.benzinga.com/pressreleases/24/05/g38566932/emergent-biosolutions-reports-first-quarter-2024-financial-results">quarterly earnings</a> of 59 cents per share, which beat the analyst consensus estimate of losses of 83 cents by 171.08%. 
Quarterly sales clocked in at $300.4 million, which beat the analyst consensus estimate of $224.5 million by 33.81% and represents an 82.84% increase from the same period last year.
The company also <a href="https://www.benzinga.com/pressreleases/24/05/g38564390/emergent-biosolutions-announces-strategic-operational-changes-to-stabilize-financial-position">announced </a>the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities and restructures its enterprise workforce to improve its performance and profitability.&nbsp;
Emergent will shut down both its Baltimore-Bayview Drug Substance manufacturing facility and Rockville, Maryland Drug Product facility. The company will also reduce its workforce by 300 employees across all areas of the company, and eliminate approximately 85 positions that are currently vacant. 
The company expects savings of approximately $80 million when fully implemented. Costs associated with the restructuring plan are estimated to be approximately $18 million to $21 million and are expected to be primarily incurred in the second half of 2024.
Emergent raised its revenue guidance for 2024 to between $1 billion and $1.1 billion.&nbsp;
Related News: <a href="https://www.benzinga.com/news/earnings/24/05/38567768/enovix-stock-soars-on-blockbuster-q1-sales">Enovix Stock Soars On Blockbuster Q1 Sales</a>
<h2 class="wp-block-heading">EBS Stock Prediction 2024: </h2>
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Emergent BioSolutions, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. 
If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Emergent BioSolutions, the 200-day moving average sits at $3.04, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, which is below the current price of $3.99. For more on charts and trend lines, <a href="https://pro.benzinga.com/">see a description here.</a>
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
EBS Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Emergent BioSolutions shares closed 70.9% higher at $3.30 on Thursday. 
Image: Gerd Altmann from Pixabay

Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Thursday.
The Dow traded up 0.87% to 38,234.10 while the NASDAQ rose 1.45% to 15,832.17. The S&amp;P 500 also rose, gaining, 0.90% to 5,063.69.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582499/top-4-defensive-stocks-youll-regret-missing-this-quarter">Top 4 Defensive Stocks You&#8217;ll Regret Missing This Quarter</a>
Leading and Lagging Sectors Information technology shares rose by 1.1% on Thursday.
In trading on Thursday, materials shares fell by 0.8%.
Top Headline
Dentsply Sirona Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) shares fell around 5% on Thursday after reporting first-quarter results.
The company reported adjusted earnings per share of 42 cents, in line with the street view. Quarterly revenues of $953 million missed the street view of $969.136 million.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Aspen Aerogels, Inc.. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares shot up 52% to $23.11 after the company reported better-than-expected first-quarter financial results.</li>
<li>Shares of Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) got a boost, surging 100% to $3.8616 after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) shares were also up, gaining 30% to $112.98 after the company reported upbeat sales for the first quarter.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) shares dropped 34% to $8.49 after the company reported first-quarter financial results.</li>
<li>Shares of Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) were down 40% to $11.07 after the company reported worse-than-expected second-quarter results and lowered its fiscal 2024 outlook.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) was down, falling 33% to $36.31 after the company reported worse-than-expected first-quarter financial results and slashed its annual revenue growth projection.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38582620/jim-cramer-this-pc-maker-is-a-good-stock-to-own-okta-is-terrific">Jim Cramer: This PC Maker Is A &#8216;Good Stock To Own&#8217;, Okta Is &#8216;Terrific&#8217; </a>
Commodities In commodity news, oil traded down 0.1% to $78.94 while gold traded up 0.2% at $2,316.20.
Silver traded up 0.3% to $26.83 on Thursday, while copper fell 1.3% to $4.4850.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.22%, Germany's DAX fell 0.20% and France's CAC 40 fell 0.88%. Spain's IBEX 35 Index gained 0.16%, while London's FTSE 100 rose 0.63%.
The HCOB Eurozone manufacturing PMI edged higher to 45.7 in April versus the preliminary reading of 45.6. Germany's manufacturing PMI climbed to 42.5 in April from 41.9 in the prior month, while French manufacturing PMI declined to 45.3 in April versus 46.2 in March.
Asia Pacific Markets
Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 falling 0.10%, Hong Kong's Hang Seng Index jumping 2.5% and S&amp;P BSE Sensex gaining 0.17%.
Hong Kong's economy grew 2.7% year-over-year in the first quarter compared to a 4.3% increase in the prior period, while the Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.
The HSBC India manufacturing PMI was revised lower to 58.8 in April compared to preliminary reading of 59.1. The consumer confidence index for Japan fell to 38.3 in April versus 39.5 a month ago.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Economics
<ul>
<li>The trade deficit in the US narrowed slightly to $69.4 billion in March versus a revised $69.5 billion gap in February.</li>
<li>Exports of goods and services fell by $5.3 billion to $257.6 billion in March, while imports into the US fell by 1.6% to $327 billion.</li>
<li>U.S. initial jobless claims came in unchanged from the previous week at 208,000 during the week ending April 27, compared to market expectations of 212,000.</li>
<li>Unit labor costs in the U.S. nonfarm business sector rose an annualized 4.7%, while nonfarm business sector labor productivity increased by 0.3% in the first quarter.</li>
<li>U.S. factory orders increased by 1.6% from the prior month to $584.5 billion in March.</li>
<li>U.S. natural-gas supplies increased 59 billion cubic feet during the week ended April 26.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582505/wall-streets-most-accurate-analysts-say-buy-these-3-utilities-stocks-with-over-3-dividen">Wall Street&#8217;s Most Accurate Analysts Say Buy These 3 Utilities Stocks With Over 3% Dividend Yields</a>

U.S. stocks traded higher midway through trading, with the Dow Jones index surging over 100 points on Thursday.
The Dow traded up 0.32% to 38,024.10 while the NASDAQ rose 0.74% to 15,720.29. The S&amp;P 500 also rose, gaining, 0.31% to 5,033.86.                                         .
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582499/top-4-defensive-stocks-youll-regret-missing-this-quarter">Top 4 Defensive Stocks You&#8217;ll Regret Missing This Quarter</a>
Leading and Lagging Sectors Information technology shares rose by 1% on Thursday.
In trading on Thursday, materials shares fell by 1%.
Top Headline
ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) reported downbeat earnings for its first quarter.
ConocoPhillips posted adjusted earnings of $2.03 per share, missing market estimates of $2.04 per share. The company's quarterly sales came in at $14.476 billion versus expectations of $15.047 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Aspen Aerogels, Inc.. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares shot up 46% to $22.19 after the company reported better-than-expected first-quarter financial results.</li>
<li>Shares of Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) got a boost, surging 129% to $4.4199 after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) shares were also up, gaining 39% to $121.17 after the company reported upbeat sales for the first quarter.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) shares dropped 34% to $8.55 after the company reported first-quarter financial results.</li>
<li>Shares of Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) were down 50% to $9.22 after the company reported worse-than-expected second-quarter results and lowered its fiscal 2024 outlook.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) was down, falling 33% to $35.88 after the company reported worse-than-expected first-quarter financial results and slashed its annual revenue growth projection.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38582620/jim-cramer-this-pc-maker-is-a-good-stock-to-own-okta-is-terrific">Jim Cramer: This PC Maker Is A &#8216;Good Stock To Own&#8217;, Okta Is &#8216;Terrific&#8217; </a>>
Commodities In commodity news, oil traded down 0.2% to $78.81 while gold traded down 0.1% at $2,310.90.
Silver traded up 0.9% to $26.99 on Thursday, while copper fell 0.9% to $4.5055.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.19%, Germany's DAX fell 0.21% and France's CAC 40 fell 0.75%. Spain's IBEX 35 Index gained 0.03%, while London's FTSE 100 rose 0.60%.
The HCOB Eurozone manufacturing PMI edged higher to 45.7 in April versus the preliminary reading of 45.6. Germany's manufacturing PMI climbed to 42.5 in April from 41.9 in the prior month, while French manufacturing PMI declined to 45.3 in April versus 46.2 in March.
Asia Pacific Markets
Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 falling 0.10%, Hong Kong's Hang Seng Index jumping 2.5% and S&amp;P BSE Sensex gaining 0.17%.
Hong Kong's economy grew 2.7% year-over-year in the first quarter compared to a 4.3% increase in the prior period, while the Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.
The HSBC India manufacturing PMI was revised lower to 58.8 in April compared to preliminary reading of 59.1. The consumer confidence index for Japan fell to 38.3 in April versus 39.5 a month ago.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Economics
<ul>
<li>The trade deficit in the US narrowed slightly to $69.4 billion in March versus a revised $69.5 billion gap in February.</li>
<li>Exports of goods and services fell by $5.3 billion to $257.6 billion in March, while imports into the US fell by 1.6% to $327 billion.</li>
<li>U.S. initial jobless claims came in unchanged from the previous week at 208,000 during the week ending April 27, compared to market expectations of 212,000.</li>
<li>Unit labor costs in the U.S. nonfarm business sector rose an annualized 4.7%, while nonfarm business sector labor productivity increased by 0.3% in the first quarter.</li>
<li>U.S. factory orders increased by 1.6% from the prior month to $584.5 billion in March.</li>
<li>U.S. natural-gas supplies increased 59 billion cubic feet during the week ended April 26.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582505/wall-streets-most-accurate-analysts-say-buy-these-3-utilities-stocks-with-over-3-dividen">Wall Street&#8217;s Most Accurate Analysts Say Buy These 3 Utilities Stocks With Over 3% Dividend Yields</a>

<h3>Gainers</h3>
<ul>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock moved upwards by 40.1% to $0.19. The market value of their outstanding shares is at $1.2 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) shares increased by 40.05% to $1.76. The company's market cap stands at $44.2 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) shares rose 36.26% to $1.42. The company's market cap stands at $9.3 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 32.35% to $0.3. The company's market cap stands at $85.5 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 25.37% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares fell 27.6% to $1.57 during Thursday's regular session. The market value of their outstanding shares is at $155.6 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) shares fell 17.62% to $5.8. The market value of their outstanding shares is at $217.3 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) stock fell 11.26% to $3.55. The company's market cap stands at $172.7 million. The company's, Q1 earnings came out today. </li>
<li>Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) stock fell 11.13% to $70.24. The company's market cap stands at $10.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 10.97% to $1.34. The company's market cap stands at $46.4 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock declined by 10.84% to $3.0. The market value of their outstanding shares is at $144.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAY

BCAB

BRKR

ELEV

JAGX

NUWE

OCEA

SNSE

SYRA

TTNP

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.48% to 38,085.28 while the NASDAQ rose 0.91% to 15,748.02. The S&amp;P 500 also rose, gaining, 0.63% to 5,050.25.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582499/top-4-defensive-stocks-youll-regret-missing-this-quarter">Top 4 Defensive Stocks You&#8217;ll Regret Missing This Quarter</a>
Leading and Lagging Sectors Information technology shares rose by 1% on Thursday.
In trading on Thursday, materials shares fell by 1%.
Top Headline
Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>)  reported better-than-expected first-quarter financial results.
Kellanova reported a first-quarter FY24 sales decline of 4.3% year-on-year to $3.20 billion, beating the analyst consensus estimate of $3.16 billion. Adjusted EPS of $1.01 beat the consensus estimate of 85 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Allarity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares shot up 95% to $2.6801 after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.</li>
<li>Shares of Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) got a boost, surging 69% to $3.2750 after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.</li>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares were also up, gaining 57% to $3.4600. Safe &amp; Green Holdings reported its collaboration and sales of modular units to Britten Inc.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) shares dropped 37% to $8.15 after the company reported first-quarter financial results.</li>
<li>Shares of Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) were down 34% to $12.18 after the company reported worse-than-expected second-quarter results and lowered its fiscal 2024 outlook.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) was down, falling 27% to $39.16 after the company reported worse-than-expected first-quarter financial results and slashed its annual revenue growth projection.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/05/38582620/jim-cramer-this-pc-maker-is-a-good-stock-to-own-okta-is-terrific">Jim Cramer: This PC Maker Is A &#8216;Good Stock To Own&#8217;, Okta Is &#8216;Terrific&#8217; </a>
Commodities In commodity news, oil traded up 0.9% to $79.71 while gold traded down 0.2% at $2,307.10.
Silver traded down 1% to $26.48 on Thursday, while copper fell 1.4% to $4.4830.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.1%, Germany's DAX gained 0.1% and France's CAC 40 fell 0.7%. Spain's IBEX 35 Index gained 0.4%, while London's FTSE 100 rose 0.4%.
The HCOB Eurozone manufacturing PMI edged higher to 45.7 in April versus the preliminary reading of 45.6. Germany's manufacturing PMI climbed to 42.5 in April from 41.9 in the prior month, while French manufacturing PMI declined to 45.3 in April versus 46.2 in March.
Asia Pacific Markets
Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 falling 0.10%, Hong Kong's Hang Seng Index jumping 2.5% and S&amp;P BSE Sensex gaining 0.17%.
Hong Kong's economy grew 2.7% year-over-year in the first quarter compared to a 4.3% increase in the prior period, while the Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.
The HSBC India manufacturing PMI was revised lower to 58.8 in April compared to preliminary reading of 59.1. The consumer confidence index for Japan fell to 38.3 in April versus 39.5 a month ago.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Economics
<ul>
<li>The trade deficit in the US narrowed slightly to $69.4 billion in March versus a revised $69.5 billion gap in February.</li>
<li>Exports of goods and services fell by $5.3 billion to $257.6 billion in March, while imports into the US fell by 1.6% to $327 billion.</li>
<li>U.S. initial jobless claims came in unchanged from the previous week at 208,000 during the week ending April 27, compared to market expectations of 212,000.</li>
<li>Unit labor costs in the U.S. nonfarm business sector rose an annualized 4.7%, while nonfarm business sector labor productivity increased by 0.3% in the first quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38582505/wall-streets-most-accurate-analysts-say-buy-these-3-utilities-stocks-with-over-3-dividen">Wall Street&#8217;s Most Accurate Analysts Say Buy These 3 Utilities Stocks With Over 3% Dividend Yields</a>

ALLR

SGBX

Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results

ALLR: 151% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38580345">Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.</a>
LUNG: 29% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38577676">Pulmonx shares are trading higher after the company reported better-than-expected Q1 financial results.</a>
EBS: 83% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38575751">Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.</a>

LUNG

Market-Moving News May 2nd

<h3>Gainers</h3>
<ul>
<li>Allarity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares moved upwards by 52.84% to $2.95. The market value of their outstanding shares is at $154.5 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock rose 35.41% to $1.3. The company's market cap stands at $4.6 million. </li>
<li>Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) stock rose 34.55% to $1.83. The company's market cap stands at $29.2 million. </li>
<li>Skye Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYE#NASDAQ">SKYE</a>) stock increased by 25.09% to $16.0. The company's market cap stands at $449.0 million. </li>
<li>Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) stock increased by 24.52% to $0.98. The market value of their outstanding shares is at $203.9 million. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) stock fell 12.5% to $0.1 during Thursday's pre-market session. The market value of their outstanding shares is at $1.2 million. </li>
<li>CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) stock fell 11.7% to $4.53. The company's market cap stands at $306.8 million. </li>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) stock decreased by 11.06% to $1.93. The market value of their outstanding shares is at $191.4 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares decreased by 10.92% to $0.68. The market value of their outstanding shares is at $29.5 million. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) stock declined by 9.95% to $0.62. The company's market cap stands at $119.8 million. </li>
<li>Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares decreased by 9.86% to $9.42. The company's market cap stands at $634.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

APVO

BFLY

CNTX

CTMX

DBVT

PHAR

SKYE

12 Health Care Stocks Moving In Thursday's Pre-Market Session

WIIM

Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.

Shares of Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/ASPN/earnings">first-quarter financial results</a>.
Aspen Aerogels posted a GAAP loss of 2 cents per share, compared to market expectations for a loss of 11 cents per share. The company's quarterly sales came in at $94.501 million versus estimates of $75.004 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Aspen Aerogels shares jumped 26.2% to $19.21 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) gained 72.1% to $3.32 in pre-market trading after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.</li>
<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) gained 38.5% to $1.33 in pre-market trading after jumping around 35% on Wednesday.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 34.8% to $117.46 in today's pre-market trading after the company announced upbeat quarterly results.</li>
<li>Enovix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) jumped 21.4% to $7.90 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>Ondas Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) shares gained 16.5% to $0.97 in pre-market trading.</li>
<li>Butterfly Network, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) shares gained 15.6% to $0.9101 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
<li>Rent the Runway, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) shares rose 14.2% to $14.14 in pre-market trading after surging 22% on Wednesday.</li>
<li>Prime Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) shares gained 13.8% to $6.00 in pre-market trading after gaining 7% on Wednesday.</li>
<li>Rush Street Interactive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) shares rose 12.6% to $7.23 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) fell 31.8% to $8.82 in pre-market trading after the company reported first-quarter financial results. The company said it expects second-quarter revenue in a range of $130 million and $134 million, versus the $140.16 million analyst estimate.</li>
<li>Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) shares declined 28.6% to $13.02 in pre-market trading after the company reported first-quarter financial results and announced a CEO transition. Baird analyst Rob Oliver downgraded Freshworks from Outperform to Neutral and lowered the price target from $28 to $16.</li>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) fell 17.4% to $4.24 in pre-market trading. CytomX Therapeutics shares jumped 215% on Wednesday after the company announced that it will report first-quarter 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.</li>
<li>Remitly Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) shares fell 16.7% to $14.58 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) shares fell 13.2% to $60.45 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) fell 12.5% to $111.50 pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>IM Cannabis Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) shares declined 11.2% to $0.9858 in pre-market trading after gaining around 29% on Wednesday.</li>
<li>Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares fell 10.6% to $100.00 in pre-market trading following weak first-quarter guidance.</li>
<li>Visionary Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) shares declined 11.8% to $0.20 in pre-market trading after falling 6% on Wednesday.</li>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) fell 6.5% to $39.19 pre-market trading after the company reported its first-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38573272/investor-optimism-improves-slightly-following-fed-decision">Investor Optimism Improves Slightly Following Fed Decision</a>

Pre-Market Outlook

DASH

ENVX

ETSY

FRSH

IMCC

ONDS

PRME

QRVO

RELY

RENT

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $(0.83) by 171.08 percent. The company reported quarterly sales of $300.400 million which beat the analyst consensus estimate of $224.500 million by 33.81 percent. This is a 82.84 percent increase over sales of $164.300 million the same period last year.

Earnings Beats

Emergent BioSolutions Q1 2024 Adj EPS $0.59 Beats $(0.83) Estimate, Sales $300.400M Beat $224.500M Estimate

2024 FINANCIAL FORECAST
The Company provides the following updated financial forecast for full year 2024 and initial forecast for Q2 2024, in both instances reflecting management's expectations based on the most current information available.
Full Year 2024
<figure class="table"> 
<table>
<tbody>
<tr>
<td>METRIC ($ in millions)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Updated Range (as of 05/01/2024)</td>
<td>Action</td>
<td>Previous Range (as of 03/06/2024)</td>
</tr>
<tr>
<td>Total revenues</td>
<td>$1,000 - $1,100</td>
<td>REVISED</td>
<td>$900 - $1,100</td>
</tr>
<tr>
<td>Net loss</td>
<td>$(148) - $(98)</td>
<td>REVISED</td>
<td>$(183) - $(133)</td>
</tr>
<tr>
<td>Adjusted net loss (2)</td>
<td>$(65) - $(15)</td>
<td>REVISED</td>
<td>$(130) - $(80)</td>
</tr>
<tr>
<td>Adjusted EBITDA (2)</td>
<td>$125 - $175</td>
<td>REVISED</td>
<td>$50 - $100</td>
</tr>
<tr>
<td>Total segment adjusted gross margin % (2)</td>
<td>44% - 47%</td>
<td>REVISED</td>
<td>40% - 45%</td>
</tr>
<tr>
<td>Segment Level Revenue (4)</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Commercial Products</td>
<td>$460 - $500</td>
<td>UNCHANGED</td>
<td>$460 - $500</td>
</tr>
<tr>
<td>MCM Products</td>
<td>$440 - $490</td>
<td>REVISED</td>
<td>$340 - $490</td>
</tr>
<tr>
<td>Services</td>
<td>$70 - $80</td>
<td>UNCHANGED</td>
<td>$70 - $80</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Key Assumptions ($ and shares in millions)</td>
<td>Updated Range (as of 05/01/2024)</td>
</tr>
<tr>
<td>Interest expense</td>
<td>~$82</td>
</tr>
<tr>
<td>R&amp;D</td>
<td>~6% of Revenue</td>
</tr>
<tr>
<td>Weighted avg. fully diluted share count</td>
<td>~52</td>
</tr>
<tr>
<td>Capex</td>
<td>~$32</td>
</tr>
<tr>
<td>Depreciation &amp; amortization</td>
<td>~$111</td>
</tr>
</tbody>
</table>
</figure>
Q2 2024
<figure class="table"> 
<table>
<tbody>
<tr>
<td>METRIC ($ in millions)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Q2 2024 Forecast</td>
</tr>
<tr>
<td>Total revenues</td>
<td>$160 - $210</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Guidance

Emergent BioSolutions Sees Q2 Revenue $160M-$210M Vs $244.5M Est.; Updates FY24 Revenue From $900M-$1B To $1B-$1.1B Vs $1.02B Est.

Management

Emergent BioSolutions Says These Actions Are Expected To Result In Annualized Savings Of ~$80M When Fully Implemented. The Costs Associated With The Restructuring Plan Are Estimated To Be ~$18M-$21M And Are Expected To Be Primarily Incurred In The Second Half Of 2024.

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position, Will Lead To A Reduction Of ~300 Employees Across All Areas Of The Company

<h3>Gainers</h3>
<ul>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares moved upwards by 25.17% to $0.92. The market value of their outstanding shares is at $2.5 million. </li>
<li>Predictive Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) shares increased by 23.4% to $1.74. The market value of their outstanding shares is at $7.0 million. </li>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) shares moved upwards by 19.0% to $0.99. The company's market cap stands at $1.7 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock moved upwards by 18.08% to $2.22. The company's market cap stands at $116.3 million. As per the press release, Q1 earnings came out today. </li>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) stock moved upwards by 17.15% to $0.64. The market value of their outstanding shares is at $42.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CVRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) stock fell 20.5% to $12.33 during Wednesday's pre-market session. The company's market cap stands at $266.2 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares declined by 18.22% to $2.11. The company's market cap stands at $22.1 million. </li>
<li>BiomX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#AMEX">PHGE</a>) shares decreased by 14.41% to $0.41. The market value of their outstanding shares is at $22.6 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock decreased by 11.8% to $1.87. The company's market cap stands at $2.4 million. </li>
<li>CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) stock decreased by 11.67% to $59.81. The market value of their outstanding shares is at $75.3 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Barinthus Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRNS#NASDAQ">BRNS</a>) stock decreased by 8.79% to $1.87. The market value of their outstanding shares is at $72.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRNS

CVRX

CYCC

LSDI

NAOV

NRXP

PHGE

POAI

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benchmark analyst Robert Wasserman reiterates Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) with a Buy and maintains $5 price target.

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $5 Price Target

Emergent BioSolutions Receives NAI Status For Baltimore Bayview Manufacturing Facility

Shares of HighPeak Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hpk#NASDAQ">HPK</a>) fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter revenue results.
HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company&rsquo;s quarterly sales came in at $301.153 million versus expectations of $339.525 million.
HighPeak Energy shares declined 15.3% to $13.49 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled &quot;Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia.&quot;</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.</li>
<li>Creative Medical Technology Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celz#NASDAQ">CELZ</a>) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipa#NASDAQ">IPA</a>) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology.</li>
<li>Beneficient (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/benf#NASDAQ">BENF</a>) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) gained 28.3% to $67.43 following strong quarterly sales.</li>
<li>CompoSecure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpo#NASDAQ">CMPO</a>) gained 27.5% to $5.99 as the company reported better-than-expected fourth-quarter financial results on Wednesday.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) rose 26% to $8.23.</li>
<li>Rush Street Interactive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rsi#NYSE">RSI</a>) gained 25.6% to $6.77 as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.</li>
<li>OneSpan Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ospn#NASDAQ">OSPN</a>) climbed 24.9% to $11.97 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>AirNet Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ante#NASDAQ">ANTE</a>) rose 24.7% to $1.51.</li>
<li>Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crbp#NASDAQ">CRBP</a>) climbed 23.2% to $41.35.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) gained 22.7% to $4.96.</li>
<li>Enhabit, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ehab#NASDAQ">EHAB</a>) rose 21.9% to $9.58 following strong quarterly results.</li>
<li>Rentokil Initial plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rto#NYSE">RTO</a>) gained 19.2% to $32.94 after the company reported better-than-expected FY23 financial results.</li>
<li>Wave Life Sciences Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wve#NYSE">WVE</a>) climbed 18.8% to $7.47. HC Wainwright &amp; Co. analyst Andrew Fein maintained WAVE Life Sciences with a Buy and raised the price target from $8 to $15.</li>
<li>The Honest Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hnst#NASDAQ">HNST</a>) rose 18.5% to $3.7301 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Dave Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dave#NYSE">DAVE</a>) gained 18.2% to $37.38.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) climbed 16.5% to $25.67.</li>
<li>Arhaus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arhs#NASDAQ">ARHS</a>) gained 15.2% to $14.77 following upbeat quarterly results.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) shares gained 13.8% to $7.89 after the company reported mixed fourth-quarter financial results and issued guidance.</li>
<li>Kronos Worldwide, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>) climbed 13.5% to $9.82 following upbeat quarterly results.</li>
<li>Avangrid, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agr#NYSE">AGR</a>) gained 12.7% to $36.15 after the company announced that the Unaffiliated Committee of its Board of Directors received a non-binding proposal from Iberdrola to acquire all common shares that it or its affiliates do not own for $34.25 in cash per share.</li>
<li>E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) gained 10.5% to $4.4750. E2open announced initiation of a strategic review.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares rose 8.8% to $4.0252 after the company entered into strategic partnership and up to $15 million equity funding agreement with Zylox-Tonbridge to access Greater China market.</li>
<li>The Kroger Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kr#NYSE">KR</a>) gained 6.9% to $53.99 after the company reported fourth-quarter EPS above estimates.</li>
<li>Yext, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yext#NYSE">YEXT</a>) shares gained 6.1% to $6.32 after the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) fell 31.6% to $32.12 after jumping 135% on Wednesday.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) dipped 30.7% to $0.5266.</li>
<li>Victoria&#39;s Secret &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) dipped 30.1% to $17.90 after reporting fourth-quarter results.</li>
<li>Methode Electronics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mei#NYSE">MEI</a>) fell 28.7% to $15.00 following weak quarterly results.</li>
<li>Nature Wood Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwgl#NASDAQ">NWGL</a>) fell 27.1% to $13.60.</li>
<li>Aptorum Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/apm#NYSE">APM</a>) shares fell 27.1% to $6.92. Aptorum shares jumped 468% on Wednesday after the company announced it entered into an agreement and plan of merger with YOOV and also announced a spin-off agreement to separate its legacy business.</li>
<li>Avid Bioservices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdmo#NASDAQ">CDMO</a>) shares fell 25.9% to $6.51 after the company reported certain preliminary third-quarter financial results and announced a proposed $160 million private placement of convertible notes.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) fell 25.1% to $5.18. Airship AI Holdings filed amended S-1 registration statement.</li>
<li>CNFinance Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnf#NYSE">CNF</a>) fell 24.6% to $1.7559.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) fell 21.5% to $2.56 after posting weak quarterly results.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) shares tumbled 15.6% to $0.7950 after surging over 27% on Wednesday.</li>
<li>Viking Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) fell 15% to $77.40. Jefferies analyst Roger Song initiated coverage on Viking Therapeutics with a Buy rating and announced a price target of $110.</li>
<li>Hudson Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hdsn#NASDAQ">HDSN</a>) fell 15% to $12.08 following fourth-quarter results.</li>
<li>Ciena Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cien#NYSE">CIEN</a>) dipped 13.8% to $53.40 after the company reported first-quarter revenue decline.</li>
<li>TriplePoint Venture Growth BDC Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpvg#NYSE">TPVG</a>) declined 13% to $9.46 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Stevanato Group S.p.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stvn#NYSE">STVN</a>) fell 10.3% to $29.70 following fourth-quarter results.</li>
<li>ADT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) shares fell 8.9% to $6.81 as the company reported pricing of secondary public offering of common stock and concurrent share repurchase.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37527817/how-to-earn-500-a-month-from-broadcom-ahead-of-q1-earnings-report"> How To Earn $500 A Month From Broadcom Ahead Of Q1 Earnings Report </a>

Penny Stocks

Small Cap

AEYE

AISP

ANTE

ARHS

AVGR

BENF

BREA

CDMO

CELZ

CERO

CIEN

CMPO

CRBP

DAVE

EHAB

ETWO

GROM

HDSN

HNST

MNMD

NEXI

NWGL

OSPN

STVN

SWIN

TPVG

VKTX

VSCO

YEXT

YGMZ

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Emergent Biosolutions shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY24 revenue guidance below estimates.

Benchmark analyst Robert Wasserman upgrades Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) from Hold to Buy and announces $5 price target.

Upgrades

Benchmark Upgrades Emergent BioSolutions to Buy, Announces $5 Price Target

Russell 2000 Q1 2024 Earnings Preview: Sharp Downward Revisions Precede Earnings Season

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out with our coverage of all the latest news happening on Thursday!



We&rsquo;re knee-deep in earnings seasons as several companies release results for the first quarter of 2024 today.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Emergent BioSolutions (NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock is rocketing close to 70% alongside <a href="https://www.nasdaq.com/press-release/emergent-biosolutions-reports-first-quarter-2024-financial-results-2024-05-01">strong Q1 earnings</a>.</li>



<li>Carvana (NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) shares are soaring more than 37% alongside its <a href="https://finance.yahoo.com/news/carvana-announces-record-first-quarter-201000815.html">Q1 2024 earings</a>.</li>



<li>Syra Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/syra-stock-quote/">SYRA</a>) stock is surging over 34% after announcing the date for its <a href="https://www.nasdaq.com/press-release/syra-health-to-discuss-first-quarter-2024-financial-results-2024-05-01">next earnings report</a>.</li>



<li>Aspen Aerogels (NYSE:<a href="https://investorplace.com/stock-quotes/aspn-stock-quote/">ASPN</a>) shares are increasing more then 26% after beating <a href="https://www.zacks.com/amp/stock/news/2266441/aspen-aerogels-aspn-surpasses-q1-earnings-and-revenue-estimates">Q1 EPS and revenue estimates</a>. </li>



<li>Tungray Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/trsg-stock-quote/">TRSG</a>) stock is gaining over 25% on Thursday morning.</li>



<li>Enovix (NASDAQ:<a href="https://investorplace.com/stock-quotes/envx-stock-quote/">ENVX</a>) shares are rising more than 23% after releasing its <a href="https://www.globenewswire.com/news-release/2024/05/01/2873598/0/en/Enovix-Announces-First-Quarter-2024-Financial-Results.html">Q1 earnings results</a>.</li>



<li>SCHMID Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHMD#NASDAQ">SHMD</a>) stock is climbing over 23% following its <a href="https://finance.yahoo.com/news/schmid-group-closes-business-combination-133500737.html">public debut yesterday</a>.</li>



<li> Pulmonx (NASDAQ:<a href="https://investorplace.com/stock-quotes/lung-stock-quote/">LUNG</a>) shares are heading more than 23% higher after <a href="https://www.msn.com/en-us/money/markets/lung-stock-earnings-pulmonx-beats-eps-beats-revenue-for-q1-2024/ar-AA1o0CfW?ocid=finance-verthp-feeds">beating EPS and revenue estimates</a> in Q1.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) stock is jumping over 21% on Thursday morning.</li>



<li>Evolus (NASDAQ:<a href="https://investorplace.com/stock-quotes/eols-stock-quote/">EOLS</a>) shares are up more than 20% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Fastly (NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/">FSLY</a>) stock is plummeting over 33% on a <a href="https://finance.yahoo.com/news/fastly-announces-first-quarter-2024-200500341.html">weak earnings forecast</a>.</li>



<li>Freshworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/frsh-stock-quote/">FRSH</a>) shares are diving nearly 29% as its <a href="https://finance.yahoo.com/news/freshworks-inc-frsh-q1-2024-213448310.html">founder and CEO steps down</a>.</li>



<li>Remitly Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/rely-stock-quote/">RELY</a>) stock is tumbling more than 16% alongside its <a href="https://www.tipranks.com/news/company-announcements/remitly-global-unveils-new-investor-presentation-update">most recent earnings report</a>.</li>



<li>Etsy (NASDAQ:<a href="https://investorplace.com/stock-quotes/etsy-stock-quote/">ETSY</a>) shares are taking an over 14% beating as <a href="https://finance.yahoo.com/video/etsy-stock-falling-q1-earnings-203137769.html">headwinds affected Q1 earnings</a>.</li>



<li>IM Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/imcc-stock-quote/">IMCC</a>) stock is retreating more than 14% <a href="https://investorplace.com/2024/05/why-is-im-cannabis-imcc-stock-up-49-today/">following a rally yesterday</a>.</li>



<li>Plutonian Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/pltn-stock-quote/">PLTN</a>) shares are dropping 14% this morning.</li>



<li>CytomX Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ctmx-stock-quote/">CTMX</a>) stock is sliding over 13% after <a href="https://investorplace.com/2024/05/why-is-cytomx-ctmx-stock-up-180-today/">rallying on Wednesday</a>.</li>



<li>DoorDash (NASDAQ:<a href="https://investorplace.com/stock-quotes/dash-stock-quote/">DASH</a>) shares are falling more than 12% <a href="https://apnews.com/article/doordash-earnings-first-quarter-results-175d32378137171b8831c617fa05c70a">despite beating Q1 estimates</a>.</li>



<li>Carver Bancorp (NASDAQ:<a href="https://investorplace.com/stock-quotes/carv-stock-quote/">CARV</a>) stock is decreasing 12% on Thursday.</li>



<li>Wolfspeed (NYSE:<a href="https://investorplace.com/stock-quotes/wolf-stock-quote/">WOLF</a>) shares are down over 11% as <a href="https://finance.yahoo.com/news/wolfspeed-reports-financial-results-third-200500488.html">fiscal Q3 earnings</a> failed to impress investors.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Carvana&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) stock is rocketing higher on Thursday after the used-car retailer posted its earnings report for the <a href="https://finance.yahoo.com/news/carvana-announces-record-first-quarter-201000815.html">first quarter of 2024</a>.



Carvana&nbsp;starts its report strong with adjusted earnings per share of 23 cents. That&rsquo;s a surprise profit compared to Wall Street&rsquo;s estimate of -74 cents per share. It&rsquo;s also a major improvement over its Q1 2023 EPS of -74 cents.



Revenue coming in at $3.06 billion is another win for CVNA stock. That has it surpassing analysts&rsquo; estimate of $2.69 billion for the quarter. It also represents a 17% increase year-over-year from $2.61 billion.



Carvana&nbsp;founder and CEO Ernie Garcia said the following about these results.




&ldquo;In the first quarter, we delivered our best results in company history, validating our long-held belief that Carvana&rsquo;s online retail model can drive industry-leading profitability while delivering industry-leading customer experiences. We reached new Q1 milestones for all key profitability metrics while also growing 16% year over year.&rdquo;




<h2>CVNA Stock Guidance</h2>



Carvana&nbsp;also includes an outlook for Q2 2024 in its latest earnings report. This sees it expecting a sequential increase in year-over-year growth rate in retail units. It also expects a sequential increase in Adjusted EBITDA.



CVNA stock is up 36.3% as of Thursday morning and was up 78.2% year-to-date when markets closed yesterday.



Investors will find even more of the most recent stock market stories below!



We have all of the hottest market news worth reading about on Thursday! Among that is why shares of Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock are up, the biggest pre-market stock movers this morning and more. All of that news is available at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-emergent-biosolutions-ebs-stock-up-57-today/">Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-2nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/05/should-you-buy-lucid-motors-lcid-stock-before-may-6/">Should You Buy Lucid Motors (LCID) Stock Before May 6?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-carvana-cvna-stock-up-36-today/">Why Is Carvana (CVNA) Stock Up 36% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Carvana (CVNA) Stock Up 36% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock is taking off on Thursday after surprising investors with <a href="https://www.nasdaq.com/press-release/emergent-biosolutions-reports-first-quarter-2024-financial-results-2024-05-01">strong Q1 2024 earnings results</a>.



The life sciences company reported adjusted earnings per share of 59 cents for the quarter. That&rsquo;s a massive beat compared to Wall Street&rsquo;s estimate of -86 cents per share. It&rsquo;s also a major improvement over the -$3.26 reported in the same period of the year prior.



Adding to that success is Emergent BioSolutions&rsquo; revenue of $300.4 million. Yet again, that blows past analysts&rsquo; estimate of $220.25 million for the quarter. It&rsquo;s also an 83% increase year-over-year from $164.3 million.



Emergent BioSolutions president and CEO Joe Papa said the following in the earnings report.




&ldquo;We delivered a strong quarter with growth across all our key products. We also took significant actions to improve our debt position, reduce operating expenses and strengthen our financial flexibility.&rdquo;




<h2>What&rsquo;s Next for EBS Stock?</h2>



Emergent BioSolutions&rsquo; outlook for Q2 2024 gives investors some ideas of what to expect from the company. This has it predicting revenue ranging from $160 million to $210 million. For comparison, Wall Street&rsquo;s Q1 revenue estimate is sitting at $244.5 million.



Emergent BioSolutions also increased its 2024 revenue guidance to between $1 billion and $1.1 billion. Before this, that range was $900 million to $1.1 billion. Wall Street is looking for $1.02 billion in 2024.



EBS stock is up 57% as of Thursday morning with nearly 5 million shares traded. That&rsquo;s well above its daily average of about 3.1 million shares.



Investors will want to stick around for even more of the most recent stock market stories.



We have all of the hottest stock market news that traders need to know about on Thursday! That includes the biggest pre-market stock movers this morning, Lucid&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lcid-stock-quote/">LCID</a>) stock news and more. All of this info is ready to go at the links below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-2nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/05/should-you-buy-lucid-motors-lcid-stock-before-may-6/">Should You Buy Lucid Motors (LCID) Stock Before May 6?</a></li>



<li><a href="https://investorplace.com/2024/05/get-ready-for-fed-rate-cuts-how-a-seemingly-niche-new-fed-policy-decision-is-paving-the-way-for-change/">Get Ready for Fed Rate Cuts: How a Seemingly Niche New Fed Policy Decision Is Paving the Way for Change</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-emergent-biosolutions-ebs-stock-up-57-today/">Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Fastly&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/">FSLY</a>) stock is falling on Thursday following the release of its earnings report for the <a href="https://finance.yahoo.com/news/fastly-announces-first-quarter-2024-200500341.html">first quarter of 2024</a>.



Weighing on FSLY stock today is the cloud platform company&rsquo;s outlook in this report. It expects Q2 EPS to range from -10 cents to -6 cents alongside revenue between $130 million and $134 million. For comparison, Wall Street&rsquo;s Q2 estimates include EPS of -2 cents on $140.16 million in revenue.



Also not helping matters is Fastly&rsquo;s guidance for 2024. The company is expecting EPS ranging from -12 cents to -6 cents with revenue being between $555 million and $565 million. To put that in perspective, analysts&rsquo; estimates include EPS of -3 cents and revenue of $584.59 million for the year.



Fastly CEO Todd Nightingale said the following in the earnings report.




&ldquo;I am pleased with the first quarter operating performance, posting non-GAAP operating loss above our guidance and positive cash flow from operations. But, we&rsquo;re not satisfied with our revenue growth outlook.&rdquo;




<h2>FSLY Stock Falls on Q1 Results</h2>



The Q1 earnings report from Fastly is mixed with it reporting EPS of -5 cents on revenue of $133.52 million. That has EPS beating Wall Street estimate of -6 cents while its revenue lags behind analysts&rsquo; estimate of $133.87 million.



FSLY stock is down 36.2% as of Thursday morning. That builds on a 26.1% drop year-to-date when markets closed yesterday.



There are plenty more stock market stories that traders will want to read about today!



We have all of that news ready to go with our coverage of the stock market for Thursday! A few examples include what has shares of Carvana&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) and Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock up today as well as the biggest pre-market stock movers this morning. All of that news is available at the links below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-carvana-cvna-stock-up-36-today/">Why Is Carvana (CVNA) Stock Up 36% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-emergent-biosolutions-ebs-stock-up-57-today/">Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-2nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-fastly-fsly-stock-down-36-today/">Why Is Fastly (FSLY) Stock Down 36% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Fastly (FSLY) Stock Down 36% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Freshworks&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/frsh-stock-quote/">FRSH</a>) stock is falling on Thursday after the software development company announced that founder and CEO Girish Mathrubootham is stepping down.



This will have Mathrubootham <a href="https://finance.yahoo.com/news/freshworks-inc-frsh-q1-2024-213448310.html">leave the CEO role</a> to take over as the executive chairman of Freshworks. That has Dennis Woodside taking over as the next president and CEO of the company.



News of Mathrubootham giving up the CEO position is pulling FRSH stock down today despite a strong Q1 earnings report. That includes adjusted EPS of 10 cents and revenue of $165.1 million. Both of these surpassed Wall Street&rsquo;s estimates of 8 cents per share and $163.52 million in revenue.



Freshworks&nbsp;also reported improved liquidity in Q1 2024 at $40.6 million. That&rsquo;s a major increase compared to its $11.5 million in liquidity reported in the first quarter of 2023.



<h2>FRSH Stock Falls on Guidance</h2>



Unfortunately, Freshworks&rsquo; outlook for Q2 includes revenue ranging from $168 million to $170 million. That&rsquo;s going to miss Wall Street&rsquo;s estimate of $172.08 million for the period.



Adding to that is the company&rsquo;s 2024 revenue guidance of $695 million to $705 million. Yet again, that wouldn&rsquo;t reach analysts&rsquo; revenue estimate of $708.35 million for the year.



FRSH stock is down 29% as of Thursday morning. Investors will note the stock was already down 17.4% year-to-date when markets closed yesterday.



There are even more stock market stories traders will want to read about today below!



We have all of the biggest stock market news that investors need to know about on Thursday! That includes everything happening with Fastly&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/">FSLY</a>) stock, Carvana&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) stock and Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock this morning. You can catch up on all of that news at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-fastly-fsly-stock-down-36-today/">Why Is Fastly (FSLY) Stock Down 36% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-carvana-cvna-stock-up-36-today/">Why Is Carvana (CVNA) Stock Up 36% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-emergent-biosolutions-ebs-stock-up-57-today/">Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-freshworks-frsh-stock-down-17-today/">Why Is Freshworks (FRSH) Stock Down 17% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Freshworks (FRSH) Stock Down 17% Today?

CytomX Therapeutics, Allarity Therapeutics, Pulmonx among healthcare movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) layoffs are in the news as the life sciences company prepares to cut jobs and close down certain facilities.



According to a release from Emergent BioSolutions, these layoffs will affect <a href="https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-announces-strategic-operational-changes">300 of its employees</a>. The company also says that it will be closing 85 open positions that are currently vacant.



The job cuts will also see Emergent BioSolutions close down two of its locations. That includes its Baltimore-Bayview Drug Substance manufacturing facility and&nbsp;Rockville, Maryland&nbsp;Drug Product facility.



Emergent BioSolutions says these layoffs will result in annual savings of $80 million. The company will deal with $18 million to $21 million restructuring charges connected to these actions in the second half of the year.



Emergent BioSolutions CEO Joe Papa said this about the layoffs.




&ldquo;Today&rsquo;s actions are about the future of Emergent. We have put in place a multi-year plan to position Emergent for sustainable and long-term success, and that starts by stabilizing our operations, strengthening our balance sheet and managing our debt.&rdquo;




<h2>Emergent BioSolutions Layoffs Extended</h2>



Investors will remember that Emergent BioSolutions announced similar layoffs just a couple of years ago after a cross-contamination case. This saw a large amount of Covid-19 vaccines discarded. Afterward, the company shifted focus away from contract manufacturing and cut roughly 400 jobs.



EBS stock is up 132.1% as of Thursday morning. That comes after it posted <a href="https://investorplace.com/2024/05/why-is-emergent-biosolutions-ebs-stock-up-57-today/">positive earnings results</a> for Q1 2024.



Investors will wind more of the most recent stock market stories ready to go below!



We have all of the hottest stock market news traders need to know about on Thursday! That includes everything happening with shares of Rivian&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rivn-stock-quote/">RIVN</a>), Allarity Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) and Plug Power&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/plug-stock-quote/">PLUG</a>) stock today. All of that info is available at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/05/truist-just-cut-its-price-target-on-rivian-rivn-stock/">Truist Just Cut Its Price Target on Rivian (RIVN) Stock</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-allarity-therapeutics-allr-stock-up-39-today/">Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/plug-stock-plug-power-expands-cryogenic-sales/">PLUG Stock: Plug Power Expands Cryogenic Sales</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/emergent-biosolutions-layoffs-2024-what-to-know-about-the-latest-ebs-job-cuts/">Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
 Carvana&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) stock is on the move Thursday after the used car retailer&rsquo;s share got a <a href="https://www.cnbc.com/2024/05/02/thursdays-analyst-calls-discount-retailers-upgraded-more-good-news-for-carvana-tough-outlook-for-cvs.html">new price target</a> from JPMorgan analyst Rajat Gupta.



This has the JPMorgan analyst increasing his price target for CVNA stock from $70 per share to $130 per share. That represents a potential upside of 49.2% over its closing price yesterday. It&rsquo;s also bullish next to the <a href="https://www.marketbeat.com/stocks/NYSE/CVNA/price-target/">analysts&rsquo; consensus price prediction</a> of $70 per share.



To go along with that, Gupta upgraded the firm&rsquo;s rating for CVNA from &ldquo;neutral&rdquo; to &ldquo;overweight&rdquo; this morning. That&rsquo;s another bull stance next to the analysts&rsquo; consensus rating of hold based on 17 opinions.



<h2>Why The Bull Stance on CVNA Stock?</h2>



Here&rsquo;s what the JPMorgan analysts said about Carvana in a note obtained by CNBC.




&ldquo;The rapid progress on margin expansion and overall EBITDA, combined with existing cash on the balance sheet, should put to rest any lingering concerns around optionality to reduce debt/interest burden over time.&rdquo;




Investors will note this new price target and rating for Carvana came alongside a <a href="https://investorplace.com/2024/05/why-is-carvana-cvna-stock-up-36-today/">record Q1 earnings report</a>. The company easily beat out both EPS and revenue estimates during the quarter.



CVNA stock is up 36.1% as of Thursday morning with more than 14 million shares traded. That&rsquo;s well above its daily average of about 6.3 million shares.



There are more stock market stories worth reading about below!



We have all of the hottest stock market news ready for Thursday! Among that is what shares of Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>), Rivian&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rivn-stock-quote/">RIVN</a>) and Allarity Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) stock are moving today. All of that info is available at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/emergent-biosolutions-layoffs-2024-what-to-know-about-the-latest-ebs-job-cuts/">Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts</a></li>



<li><a href="https://investorplace.com/2024/05/truist-just-cut-its-price-target-on-rivian-rivn-stock/">Truist Just Cut Its Price Target on Rivian (RIVN) Stock</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-allarity-therapeutics-allr-stock-up-39-today/">Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/jpmorgan-just-raised-its-price-target-on-carvana-cvna-stock/">JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
MercadoLibre (NASDAQ:<a href="https://investorplace.com/stock-quotes/meli-stock-quote/">MELI</a>) stock is a hot topic on Thursday as investors are hoping the Latin America e-commerce company will announce a stock split after markets close today.



One of the reasons that traders are hoping for a stock split from MercadoLibre is the fact that the company&rsquo;s shares have <a href="https://finance.yahoo.com/news/stock-split-fever-hitting-market-054400316.html#:~:text=MercadoLibre%20has%20been%20a%20public,price%20tag%20of%20%241%2C540%20today">never undergone one before</a>. Adding to that is the increasing price of the stock, which was trading for about $1,479 as of this writing.



MercadoLibre has been on the public market for years now having made its debut back in 2007. During that time, the price of the stock has surged higher with a more than 5,000% increase since going public.



This has some investors hopeful that a MELI stock split will be announced soon. The reason investors are pinning hopes on after markets close today is due to earnings. The company will report its Q1 2024 earnings results after the closing bell.



<h2>What To Expect from MELI Today</h2>



The stock&rsquo;s movement will largely be affected by its earnings report. Wall Street is predicting EPS of $6.03 alongside revenue of $3.85 billion. Shares could also rise or fall depending on any split announcement, or lack thereof.



MELI stock is up 1.6% as of Thursday afternoon. The shares are down 3.2% since the start of the year.



Investors will find more of the most recent stock market stories ready to go below!



We have all of the hottest stock market news traders need to know about on Thursday! A few examples include what&rsquo;s going on with shares of Lucid Motors&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lcid-stock-quote/">LCID</a>), Carvana&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/">CVNA</a>) and Emergent BioSolutions&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) stock. All of that news is available at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/05/lcid-stock-lucid-motors-announces-new-saudi-ev-partnership/">LCID Stock: Lucid Motors Announces New Saudi EV Partnership</a></li>



<li><a href="https://investorplace.com/2024/05/jpmorgan-just-raised-its-price-target-on-carvana-cvna-stock/">JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock</a></li>



<li><a href="https://investorplace.com/2024/05/emergent-biosolutions-layoffs-2024-what-to-know-about-the-latest-ebs-job-cuts/">Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/mercadolibre-stock-split-will-meli-investors-see-wishes-come-true-today/">MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today?

ALKS

AMPY

AMWL

ATRC

CARV

EOLS

LCID

LNTH

MELI

NVAX

PLTN

PLUG

RIVN

SATS

SHMD

SQSP

TALO

TRSG

WOLF

Press Releases

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

General

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

Health Care

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

Contracts

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Emergent BioSolutions Stock (NYSE:EBS), Short Interest Report

People Also Watch